---
schema_version: "secwatch.filing_event.v1"
accession: "0001420720-23-000072"
form_type: "8-K"
ticker: "IBIO"
cik: "0001420720"
company_name: "iBio, Inc."
filed_at: "2023-12-26T23:59:59+00:00"
generated_at: "2026-06-07T07:17:12.034927+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# iBio amends credit agreement: maturity extended to March 29, 2024, rate cut to 4.5%

## Summary
- Maturity extended from Dec 31, 2023 to earlier of March 29, 2024 or acceleration of term loan.
- Interest rate reduced from 5.25% to 4.5%; payment-in-kind increased from 3% to 4.5%.
- Borrower must maintain minimum $900K reserve; best efforts to sell cGMP manufacturing facility before maturity.
- Woodforest fee increased by $10,000 to $155,000, payable at sale closing or maturity date.
- Amendment provides additional flexibility to complete divestiture of CDMO business and advance AI immunotherapy platform.

## SEC filing metadata
- accession: 0001420720-23-000072
- form_type: 8-K
- ticker: IBIO
- cik: 0001420720
- company_name: iBio, Inc.
- filed_at: 2023-12-26T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420720/000142072023000072/0001420720-23-000072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420720/000142072023000072/ibio-20231222x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001420720-23-000072
- JSON: https://secwatch.observer/filing/0001420720-23-000072.json
- Plain text: https://secwatch.observer/filing/0001420720-23-000072.txt

## Key facts
- Material Agreements
  iBio, Inc. amended Eighth Amendment with Woodforest National Bank (effective 2023-12-22).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Woodforest National Bank
  - Effective: 2023-12-22
  source text: On December 22, 2023, iBio CDMO LLC (“Borrower”), a wholly owned subsidiary of iBio, Inc. (the “Company”) and Woodforest National Bank (“Woodforest”) entered into the Eighth Amendment (the “Eight Amendment”) to the Credit Agreement
  evidence_url: https://www.sec.gov/Archives/edgar/data/1420720/000142072023000072/0001420720-23-000072-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.